HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Sacks, D. B. Search for Related Content PubMed PubMed Citation Articles by Sacks, D. B. Related Collections Molecular Diagnostics and Genetics Proteomics and Protein Markers Hematology Endocrinology and Metabolism

Hemoglobin Variants and Hemoglobin A_1c Analysis: Problem Solved?

¹ Department of Pathology, Brigham and Women’s Hospital, and, Harvard Medical School, Boston MA 02115

^aAddress for correspondence: Brigham and Women’s Hospital, Thorn 530, 75 Francis St., Boston, MA 02115. Fax 617-278-6921; e-mail dsacks@rics.bwh.harvard.edu

The first 300 words of the full text of this article appear below.

Measurement of glycohemoglobin (GHb) is an integral component of the management of patients with diabetes mellitus (1)(2). Glycation is the nonenzymatic addition of a sugar residue to amino groups of proteins. Numerous proteins in the body are glycated, but GHb in blood is the analyte most widely used clinically to monitor glycemic control. The concentration of GHb is directly proportional to the mean concentration of glucose in the blood and the lifespan of erythrocytes (mean, 120 days). Thus, the GHb concentration represents an integrated value for glucose over the preceding 2–3 months. GHb provides an index of glycemic control that is free of the wide diurnal glucose fluctuations and is unaffected by recent exercise or food ingestion.

Two large, prospective, randomized clinical trials demonstrated a strong relationship between hyperglycemia and the development of microvascular complications of diabetes. In the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), which studied patients with type 1 and type 2 diabetes, respectively (3)(4), glycemic control was assessed by GHb. Both studies established a direct relationship between the GHb concentration and the risk of complications. These findings led the American Diabetes Association to recommend that a primary treatment goal in adults with diabetes should be near-normal glycemia with hemoglobin A_1c (HbA_1c) <7% when measured by the method used for the DCCT (2). The recommendation that HbA_1c be measured at least every 6 months in patients with type 1 or type 2 diabetes (2) has had a dramatic impact on the use of this test. The number of laboratories participating in the GHb surveys offered by the College of American Pathologists increased from 707 in 1990 to 2008 in 2003. Clinical laboratories in the US currently perform . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				A H Berg and D B Sacks Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony J. Clin. Pathol., September 1, 2008; 61(9): 983 - 987. [Abstract] [Full Text] [PDF]

				S.-T. Lee, C. W. Weykamp, Y.-W. Lee, J.-W. Kim, and C.-S. Ki Effects of 7 Hemoglobin Variants on the Measurement of Glycohemoglobin by 14 Analytical Methods Clin. Chem., December 1, 2007; 53(12): 2202 - 2205. [Abstract] [Full Text] [PDF]

				N. Ostendorf, T. Glosemeyer-Allhoff, K. Schauerte, and R. Yamamoto Hemoglobin (Hb) Stanleyville II Causes Gross Overestimation of the Hb A1c Proportion in Routine HPLC Clin. Chem., September 1, 2005; 51(9): 1752 - 1754. [Full Text] [PDF]